Harbin Medisan Pharmaceutical Co., Ltd. (002900.SZ)

CNY 10.57

(-1.03%)

Annual Balance Sheets

(In CNY)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 3.44 Billion 3.27 Billion 3.06 Billion 2.48 Billion 2.67 Billion 2.51 Billion
Total Current Assets 1.43 Billion 1.62 Billion 1.42 Billion 1.44 Billion 1.68 Billion 1.64 Billion
Cash And Short Term Investments 1.04 Billion 1.29 Billion 1.11 Billion 1.02 Billion 1.16 Billion 556.59 Million
Cash and Cash Equivalents 991.16 Million 1.2 Billion 529.83 Million 661.44 Million 471.49 Million 451.68 Million
Short Term Investments 57.75 Million 91.25 Million 581.67 Million 360.79 Million 696.72 Million 104.9 Million
Net Receivables 150.57 Million 164.05 Million 149.63 Million 204.68 Million 256.1 Million 249.82 Million
Inventory 208.78 Million 161.16 Million 156.54 Million 186.51 Million 214.33 Million 183.93 Million
Other Current Assets 28.16 Million 4.54 Million 9.5 Million 26.72 Million 46.93 Million 654.85 Million
Total Non-Current Assets 2 Billion 1.65 Billion 1.63 Billion 1.04 Billion 986.53 Million 868.34 Million
Net PPE 1.08 Billion 882.44 Million 925.34 Million 867.29 Million 806.69 Million 725.71 Million
Good Will And Intangible Assets 142.54 Million 72.17 Million 71.94 Million 75.85 Million 79.48 Million 82 Million
Good Will 1.33 Million 500 Thousand 9.43 Million 9.43 Million 9.43 Million 9.43 Million
Intangible Assets 141.2 Million 71.67 Million 62.5 Million 66.41 Million 70.05 Million 72.56 Million
Long-Term Investments 651.23 Million 555.61 Million 22.82 Million -345.87 Million -673.32 Million -72.01 Million
Tax Assets 23.07 Million 23.81 Million 25.84 Million 23.88 Million 21.06 Million 21.56 Million
Other Non Current Assets 108.09 Million 119.08 Million 592.36 Million 421.44 Million 752.61 Million 111.07 Million
Other Assets -0.00 1.00 - 1.00 1.00 1.00
Total Liabilities 1.29 Billion 1.22 Billion 949.04 Million 691.18 Million 820.43 Million 543.78 Million
Total Current Liabilities 845.03 Million 597.73 Million 536.61 Million 588.83 Million 723.29 Million 447.19 Million
Account Payables 182.13 Million 120.83 Million 105.16 Million 90.01 Million 96.36 Million 76.81 Million
Tax Payables 3.07 Million 12.15 Million 11.15 Million 10.76 Million 31.85 Million 19.06 Million
Short Term Debt 480.21 Million 233.79 Million 274.79 Million 269.78 Million 180 Million 58 Million
Deferred Revenue 174.76 Million 54.79 Million 154.12 Million 226.97 Million 350.23 Million 19.06 Million
Other Current Liabilities 7.92 Million 188.3 Million 2.52 Million 2.07 Million 96.69 Million 293.31 Million
Total Non Current Liabilities 449.72 Million 627.06 Million 412.42 Million 102.34 Million 97.14 Million 96.59 Million
Long-Term Debt 238.15 Million 422.92 Million 212.86 Million 10.86 Million - -
Deferred Revenue Non Current 79.02 Million 83.86 Million 88.95 Million 88.71 Million 84.89 Million 90.27 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.00 1.00 1.00 -10.86 Million 1.00 -
Other Liabilities 1.00 1.00 - - 1.00 1.00
Total Equity 2.14 Billion 2.05 Billion 2.11 Billion 1.79 Billion 1.85 Billion 1.96 Billion
Stock Holders Equity 2.14 Billion 2.04 Billion 2.1 Billion 1.77 Billion 1.83 Billion 1.94 Billion
Common Stock 316.39 Million 316.6 Million 316.6 Million 316.6 Million 316.6 Million 316.6 Million
Retained Earnings 612.93 Million 570.71 Million 639.63 Million 341.23 Million 411.1 Million 462.98 Million
Accumulated other comprehensive income - 162.45 Million 192.28 Million 164.52 Million 152.07 Million 128.9 Million
Common Stock Equity 2.14 Billion 2.04 Billion 2.1 Billion 1.77 Billion 1.83 Billion 1.94 Billion
Capital Lease Obligation 8.33 Million 5.14 Million 8.02 Million 10.86 Million - -
Total Investments 708.98 Million 646.86 Million 604.5 Million 14.91 Million 23.4 Million 32.89 Million
Total Debt 718.37 Million 656.72 Million 487.66 Million 269.78 Million 180 Million 58 Million
Net Debt -272.78 Million -545.92 Million -42.16 Million -391.66 Million -291.49 Million -393.68 Million

Balance Sheet Charts